TriSalus Life Sciences Announces Commencement Of Exchange Offer, Consent Solicitation Relating To Series A Convertible Preferred Stock To Streamline Capital Structure
June 23 (Reuters) - TriSalus Life Sciences Inc TLSI.O:
TRISALUS LIFE SCIENCES ANNOUNCES COMMENCEMENT OF EXCHANGE OFFER AND CONSENT SOLICITATION RELATING TO SERIES A CONVERTIBLE PREFERRED STOCK TO STREAMLINE CAPITAL STRUCTURE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

Nvidia Stock Prediction: Can NVDA Hit $1,000 by 2030?

Robinhood Slumps 8% After Earnings. Revenue and Profit Both Miss, Market Fears Coinbase May Follow Suit.

GOOGL Vs. MSFT: 2 Monster Stocks to Hold for the Next 5 Years

Tradingkey







